What was the market valuation of the UK animal vaccines market in 2024?

The market valuation was $518.18 Million in 2024. Read More

What is the projected market valuation for the UK animal vaccines market by 2035?

The projected valuation for 2035 is $1161.0 Million. Read More

What is the expected CAGR for the UK animal vaccines market during the forecast period 2025 - 2035?

The expected CAGR is 7.61% during the forecast period 2025 - 2035. Read More

Which companies are considered key players in the UK animal vaccines market?

Key players include Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco Animal Health, Virbac, Ceva Santé Animale, Heska Corporation, and Vetoquinol. Read More

What was the valuation of Inactivated Vaccines in the UK animal vaccines market?

The valuation of Inactivated Vaccines ranged from $155.0 Million to $350.0 Million. Read More

How does the market for livestock vaccines compare to that for pets?

The livestock vaccine market valuation ranged from $150.0 Million to $350.0 Million, whereas the pet vaccine market ranged from $100.0 Million to $250.0 Million. Read More

What are the different routes of administration for animal vaccines in the UK market?

The routes of administration include Injectable, Oral, Intranasal, and Topical. Read More

What was the valuation range for Injectable vaccines in the UK animal vaccines market?

The valuation range for Injectable vaccines was from $200.0 Million to $450.0 Million. Read More

UK Animal Vaccines Market

Q: What are the main segments of the UK animal vaccines market by technology?

The main segments by technology include Inactivated Vaccines, Attenuated Vaccines, Subunit Vaccines, DNA Vaccines, and mRNA Vaccines. Read More

Q: Which distribution channels are utilized for animal vaccines in the UK market?

Distribution channels include Veterinary Clinics, Retail Pharmacies, Online Pharmacies, and Animal Hospitals. Read More

UK Animal Vaccines Market Research Report By Technology (Inactivated Vaccines, Attenuated Vaccines, Subunit Vaccines, DNA Vaccines, mRNA Vaccines), By Animal Type (Pets, Livestock, Poultry, Wildlife, Aquaculture), By Route of Administration (Injectable, Oral, Intranasal, Topical) and By Distribution Channel (Veterinary Clinics, Retail Pharmacies, Online Pharmacies, Animal Hospitals) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

7.61%

2024 Market Size

$ 518.18 Million

2035 Market Size

$ 1,161 Million

Pharmaceutical ● Updated August 2026 Report ID: MRFR/Pharma/47431-HCR | Pages: 200 | Author: Rahul Gotadki

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Technology (USD Million)
  1. 4.1.1 Inactivated Vaccines
  2. 4.1.2 Attenuated Vaccines
  3. 4.1.3 Subunit Vaccines
  4. 4.1.4 DNA Vaccines
  5. 4.1.5 mRNA Vaccines
2. 4.2 Healthcare, BY Animal Type (USD Million)
  1. 4.2.1 Pets
  2. 4.2.2 Livestock
  3. 4.2.3 Poultry
  4. 4.2.4 Wildlife
  5. 4.2.5 Aquaculture
3. 4.3 Healthcare, BY Route of Administration (USD Million)
  1. 4.3.1 Injectable
  2. 4.3.2 Oral
  3. 4.3.3 Intranasal
  4. 4.3.4 Topical
4. 4.4 Healthcare, BY Distribution Channel (USD Million)
  1. 4.4.1 Veterinary Clinics
  2. 4.4.2 Retail Pharmacies
  3. 4.4.3 Online Pharmacies
  4. 4.4.4 Animal Hospitals
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Zoetis (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Merck Animal Health (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Boehringer Ingelheim (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Elanco Animal Health (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Virbac (FR)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Ceva Santé Animale (FR)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Heska Corporation (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Vetoquinol (FR)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 UK MARKET ANALYSIS BY TECHNOLOGY
3. 6.3 UK MARKET ANALYSIS BY ANIMAL TYPE
4. 6.4 UK MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
5. 6.5 UK MARKET ANALYSIS BY DISTRIBUTION CHANNEL
6. 6.6 KEY BUYING CRITERIA OF HEALTHCARE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF HEALTHCARE
9. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
11. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
12. 6.12 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
13. 6.13 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
14. 6.14 HEALTHCARE, BY ANIMAL TYPE, 2024 (% SHARE)
15. 6.15 HEALTHCARE, BY ANIMAL TYPE, 2024 TO 2035 (USD Million)
16. 6.16 HEALTHCARE, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)
17. 6.17 HEALTHCARE, BY ROUTE OF ADMINISTRATION, 2024 TO 2035 (USD Million)
18. 6.18 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
19. 6.19 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TECHNOLOGY, 2025-2035 (USD Million)
  2. 7.2.2 BY ANIMAL TYPE, 2025-2035 (USD Million)
  3. 7.2.3 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Million)
  4. 7.2.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

UK Animal Vaccines Market Segmentation

UK Animal Vaccines Market By UK Animal Vaccines Market (USD Million, 2025-2035)

Inactivated Vaccines
Attenuated Vaccines
Subunit Vaccines
DNA Vaccines
mRNA Vaccines

UK Animal Vaccines Market By Animal Type (USD Million, 2025-2035)

Pets
Livestock
Poultry
Wildlife
Aquaculture

UK Animal Vaccines Market By Route of Administration (USD Million, 2025-2035)

Injectable
Oral
Intranasal
Topical

UK Animal Vaccines Market By Distribution Channel (USD Million, 2025-2035)

Veterinary Clinics
Retail Pharmacies
Online Pharmacies
Animal Hospitals

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”